Inotropic action, myocardial uptake and subcellular distribution of ouabain, digoxin and digitoxin in isolated rat hearts

  • Uwe Fricke
  • Ursula Hollborn
  • Wolfgang Klaus
Article
Received:
Accepted:

Summary

In experiments on isolated, electrically driven (240/min) rat hearts, perfused via the aorta at a constant flow (3.8 ml/min), the pharmacologically effective concentration range, the myocardial uptake and the subcellular distribution of three cardiac glycosides (digitoxin, digoxin, ouabain) were determined. The following results were obtained:
  1. 1.

    The effective range varied depending on the cardiac glycoside tested: With digoxin and ouabain very similar results were found—the positive inotropic concentration ranges being within 8×10−6M and 6×10−5M, the maximum positive inotropic effects attainable being about 100% and the concentration for half maximum effects (ED-50) being 2.4×10−5M and 2.3×10−5M, respectively. With digitoxin the inotropic concentration range was found to be within 3.6×10−6M and 2.4×10−5M with a maximum inotropic effect attainable of about 50% only and an ED-50 of 9.5×10−6M. The analysis of the time course of the inotropic action revealed extremely short half times for all cardiac glycosides studied (between 48 and 54 sec).

     
  2. 2.

    The myocardial uptake correlated with the physicochemical behaviour of the three cardiac glycosides studied and was found-depending on the perfusion time (5 to 60 min)—to be in the range of 23 and 36 (ouabain), 66 and 98 (digoxin) and 169 and 264 (digitoxin) nmoles/g wet weight. The respective computed half times for these uptake processes were 2.5 min (digoxin, ouabain) and 3.4 min (digitoxin).

     
  3. 3.

    Regarding the subcellular distribution an accumulation exceeding an “unspecific” binding (non-perfused hearts) was found mainly in the nuclear-membrane fraction.

     

On the basis of these results (very short half times of either the pharmacological action and the cardiac uptake) the site of action of cardiac glycosides in the rat heart is supposed to be located at the surface membrane of the heart muscle cells. Furthermore, the above results are discussed with respect to those obtained in digitalis-sensitive species.

Key words

Cardiac Glycosides Isolated Rat Heart Inotropic Action Cardiac Uptake Subcellular Distribution 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akera, T., Larsen, F. S., Brody, T. M.: The effect of ouabain on sodium- and potassium-activated adenosine triphosphatase from the hearts of several mammalian species. J. Pharmacol. exp. Ther. 170, 17–26 (1969)Google Scholar
  2. Albrecht, B.: Über die Wirkung von Strophanthin auf Funktion und Kaliumbilanz isolierter Meerschweinchenherzen in Abhängigkeit von der extrazellulären Kaliumkonzentration. Inauguraldissertation, Mainz 1971Google Scholar
  3. Alken, R. G., Fricke, U., Klaus, W.: Divergent influences of Ca2+ on the action of several cardiotonic steroids in isolated heart muscle preparations. Europ. J. Pharmacol. 26, 331–337 (1974)Google Scholar
  4. Allen, J. C., Schwartz, A.: A possible explanation for the insensitivity of the rat to cardiac glycosides. J. Pharmacol. exp. Ther. 168, 42–46 (1969)Google Scholar
  5. Baskin, S. I., Dutta, S., Marks, B. H.: The effects of diphenylhydantoin and potassium on the biological activity of ouabain in the guinea pig heart. Brit. J. Pharmacol. 47, 85–96 (1973)Google Scholar
  6. Beckett, P. R.: The isolated perfused heart preparation: Two suggested improvements. J. Pharm. Pharmacol. 22, 818–822 (1970)Google Scholar
  7. Cattell, M., Gold, h.: The influence of digitalis glucosides on the force of contraction of mammalian cardiac muscle. J. Pharmacol. exp. Ther. 62, 116–125 (1938)Google Scholar
  8. Clark, A. J.: The factors determinating tolerance of glucosides of the digitalis series. J. Pharmacol. exp. Ther. 4, 399–424 (1913)Google Scholar
  9. Cloetta, M., Fischer, H. F.: Über das Verhalten des Digitoxins im Organismus. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 54, 294–313 (1906)Google Scholar
  10. Dal Pra, P., Rossini, L., Segre, G.: The kinetics of ouabain uptake in frog heart in relation to the kinetics of inotropic effect and to the activation of transport ATP-ases. Pharmacol. Res. Commun. 2, 177–191 (1970)Google Scholar
  11. Dransfeld, H., Greeff, K., Berger, H., Cautius, V.: Die verschiedene Empfindlichkeit der Na+−K+-aktivierten ATPase des Herz- und Skeletmuskels gegen Strophanthin. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 254, 225–235 (1966)Google Scholar
  12. Dutta, S., Goswami, S., Datta, O. K., Lindower, J. O., Marks, B. H.: The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and by isolated sarcoplasmic reticulum. J. Pharmacol. exp. Ther. 164, 10–21 (1968b)Google Scholar
  13. Dutta, S., Goswami, S., Lindower, J. O., Marks, B. H.: Subcellular distribution of digoxin-H3 in isolated guinea-pig and rat hearts. J. Pharmacol. exp. Ther. 159, 324–334 (1968a)Google Scholar
  14. Dutta, S., Marks, B. H.: Factors that regulate ouabain-H3 accumulation by the isolated guinea-pig heart. J. Pharmacol. exp. Ther. 170, 318–325 (1969)Google Scholar
  15. Dutta, S., Marks, B. H.: Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts. Brit. J. Pharmacol. 46, 401–408 (1972)Google Scholar
  16. Dutta, S., Rhee, H. M., Marks, B. H.: Effect of metabolic inhibitors on the accumulation of digitaloids by the isolated guinea-pig heart. J. Pharmacol. exp. Ther. 180, 351–358 (1972)Google Scholar
  17. Eguchi, N.: Species difference in ouabain-inhibition of (Na+−K+)-activated ATPase in muscle cell membranes from several species. Folia pharmacol. jap. 67, 362–373 (1971)Google Scholar
  18. Farah, A.: On the elimination of g-strophanthin by the rat. J. Pharmacol. exp. Ther. 86, 248–257 (1946)Google Scholar
  19. Forester, G. V., Mainwood, G. W.: Ouabain sensitivity in the rat myocardium: Correlation with a model of subcellular calcium movement. In: Myocardial Biology, Vol. 4, N. S. Dhalla, ed., pp. 273–279. München-Berlin-Wien: Urban & Schwarzenberg 1974Google Scholar
  20. Fricke, U., Gerber, H. G., Klaus, W., Wollert, U.: Vergleich der subcellulären Verteilung von 3H-Strophanthin und 3H-Digitoxin im Meerschweinchenherzen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 263, 266 (1969)Google Scholar
  21. Fricke, U., Hollborn, U., Klaus, W.: Positive inotropic action and cardiac uptake of ouabain, digoxin and digitoxin in the isolated rat heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, (Suppl.), R17 (1974)Google Scholar
  22. Fricke, U., Klaus, W.: Über die Wirkung von Strophanthidin-3-bromacetat am Papillarmuskel des Meerschweinchens. Naunyn-Schmiedebergs Arch. Pharmak. 268, 192–199 (1971)Google Scholar
  23. Fricke, U., Klaus, W.: Different dependence of the toxic action of some cardiotonic steroids on the serum potassium level in guinea pigs. Naunyn-Schmiedeberg's Arch. Pharmacol. 282 (Suppl.), R 22 (1974a)Google Scholar
  24. Fricke, U., Klaus, W.: A simple preparation technique for a microsomal Na+−K+-activated ATPase from cardiac tissues of different species. Prep. Biochem. 4, 13–29 (1974b)Google Scholar
  25. Fricke, U., Klaus, W.: Dependence of the cardiac uptake of digitalis glycosides on the extracellular calcium concentration in isolated guinea pig hearts. Europ. J. Pharmacol. 30, 182–187 (1975)Google Scholar
  26. Genuit, H.: Zur Frage der hohen Digitalisresistenz der Ratte. Untersuchung über die Glykosidspeicherung des isolierten Herzens am geschlossenen Coronarkreislauf. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 188, 285–301 (1938)Google Scholar
  27. Gerber, H.-G., Fricke, U., Klaus, W., Wollert, U.: Über die intracelluläre Verteilung von 3H-Digitoxin im Meerschweinchenherzen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 119 (1968)Google Scholar
  28. Gersmeyer, G., Holland, W. C.: Influence of ouabain on contractile force, resting tension. 45Ca-entry and tissue Ca content in rat atria. Circulat. Res. 12, 620–622 (1963)Google Scholar
  29. Goldstein, A., Aronow, L., Kalman, S. M.: Principles of drug action, p. 343. New York-Evanston-London: Hoeber Medical Division, Harper and Row 1968Google Scholar
  30. Greeff, K.: Zum Wirkungsmechanismus der Digitalisglykoside. In: Probleme der klinischen Prüfung herzwirksamer Glykoside. Kreislauf-Bücherei, Bd. 24, K. Greeff, ed., pp. 12–24. Darmstadt: Steinkopff 1968Google Scholar
  31. Greeff, K., Schlieper, E.: Artspezifische Wirkungsunterschiede des k-Strophanthins und Prednisolonbisguanylhydrazons: Untersuchungen an isolierten Vorhofpräparaten und Erythrocyten des Menschen, Meerschweinchens, Kaninchens und der Ratte. Arch. int. Pharmacodyn. 166, 350–361 (1967)Google Scholar
  32. Gunn, J. A.: The congenital tolerance of the rat to strophanthus. J. Pharmacol. exp. Ther. 4, 225–233 (1913)Google Scholar
  33. Hartley, H. O.: Modified Gauss-Newton method for fitting non-linear regression functions. Technometrics 3, 269–280 (1961)Google Scholar
  34. Heinen, E., Noack, E.: Effects of k-strophanthin and digitoxigenin on contractile force, calcium content and exchange in guinea-pig isolated atria. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 359–371 (1972)Google Scholar
  35. Heubner, W., Nyary, A. V.: Versuche zur quantitativen Erfassung der Kumulation bei Digitalisstoffen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 177, 60–73 (1935)Google Scholar
  36. Hoeschen, R. J.: The effect of ouabain on substrate metabolism in the isolated perfused rat heart. Canad. J. Physiol. Pharmacol. 49, 412–419 (1971)Google Scholar
  37. Illanes, A., Marshall, J. M.: The effects of ouabain on isolated atria of the ground squirrel; comparison with rat and rabbit atria. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 15–26 (1964)Google Scholar
  38. Ito, M., Hollander, P. B., Marks, B. H., Dutta, S.: The effects of six cardiac glycosides on the transmembrane potential and contractile characteristics of the right ventricle of guinea pigs. J. Pharmacol. exp. Ther. 172, 188–195 (1970)Google Scholar
  39. v. Kaulla, K. N.: Die Entgiftung des Digitoxins bei der weißen Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 194, 179–189 (1940)Google Scholar
  40. Kawagishi, S.: Subcellular distribution of tritium-labeled cardiac glycosides in isolated cat and guinea-pig hearts. Folia pharmacol. jap. 67, 243–251 (1971)Google Scholar
  41. Kim, N. D., Bailey, L. E., Dresel, P. E.: The effect of insulin on the subcellular distribution and the inotropic effect of 3H-digoxin in the guinea pig heart. Life Sci. (I) 9, 1135–1139 (1970)Google Scholar
  42. Kim, N. D., Bailey, L. E., Dresel, P. E.: Correlation of the subcellular distribution of digoxin with the positive inotropic effect. J. Pharmacol. exp. Ther. 181, 377–385 (1972)Google Scholar
  43. Klaus, W.: Neuere Aspekte über den Wirkungsmechanismus der Herzglykoside. Z. Naturwiss. Med. Grundlagenforsch. 2, 43–117 (1964)Google Scholar
  44. Klaus, W., Krebs, R.: Kinetische Analyse der Calcium-Kompartimente im Meerschweinchenherzen unter Kontrollbedingungen und Strophanthineinwirkung. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 277–292 (1974)Google Scholar
  45. Klaus, W., Kuschinsky, G.: Über die Wirkung von Digitoxigenin auf den zellulären Calcium-Umsatz im Herzmuskelgewebe. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 244, 237–253 (1962)Google Scholar
  46. Klaus, W., Lee, K. S.: Influence of cardiac glycosides on calcium binding in muscle subcellular components. J. Pharmacol. exp. Ther. 166, 68–76 (1969)Google Scholar
  47. Koch-Weser, J., Blinks, J. R.: Analysis of the relation of the positive inotropic action of cardiac glycosides to the frequency of contraction of heart muscle. J. Pharmacol. exp. Ther. 136, 305–317 (1962)Google Scholar
  48. Krieglstein, G., Krieglstein, J., Urban, W.: On the interaction of various drugs with synthetic materials used in pharmacological apparatus. Arzneimittel-Forsch. 22, 1538–1540 (1972)Google Scholar
  49. Lee, K. S., Klaus, W.: The subcellular basis for the mechanism of the inotropic action of cardiac glycosides. Pharmacol. Rev. 23, 193–261 (1971)Google Scholar
  50. Lendle, L.: Digitaliskörper und verwandte herzwirksame Glykoside (Digitaloide). In: Heffter's Handb. exp. Pharmakol., Erg.-Bd. I, 11–241 (1935)Google Scholar
  51. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)Google Scholar
  52. Lüllmann, H., Ravens, U.: The time courses of the changes in contractile force and in transmembrane potentials induced by cardiac glycosides in guinea-pig papillary muscle. Brit. J. Pharmacol. 49, 377–390 (1973)Google Scholar
  53. Lüllmann, H., Weber, R., van Zwieten, P. A.: The correlation between the decline of the positive inotropic effect and the loss of cardiac glycosides from isolated atria during washout. Europ. J. Pharmacol. 6, 235–240 (1969)Google Scholar
  54. Masuoka, D. T., Saunders, P. R.: Positive inotropic action of ouabain on rat ventricle strips. Proc. Soc. exp. Biol. (N. Y.) 74, 879–882 (1950)Google Scholar
  55. Mehnert, H.: Über die Prüfung der Kumulationsneigung verschiedener herzwirksamer Substanzen am Warmblüter. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 184, 181–196 (1937)Google Scholar
  56. Nayler, W. G., Dunnett, J.: A possible explanation for the peculiar contractile behaviour displayed by rat heart muscle. VI. Annual Meeting of the International Study Group for Research in Cardiac Metabolism, 25–28 September, Freiburg, R 109 (1973)Google Scholar
  57. Peters, T., Raben, R.-H., Wassermann, O.: Evidence for a dissociation between positive inotropic effect and inhibition of the Na+-K+-ATPase by ouabain, cassaine and their alkylating derivatives. Europ. J. Pharmacol. 26, 166–174 (1974)Google Scholar
  58. Prindle, K. H., Jr., Skelton, C. L., Epstein, S. F., Marcus, F. J.: Influence of extracellular potassium concentration on myocardial uptake and inotropic effect of tritiated digoxin. Circulat. Res. 28, 337–345 (1971)Google Scholar
  59. Reiter, M.: Wirkung von Strophanthin auf Kontraktionskraft und Sauerstoffverbrauch des Herzstreifens der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 219, 315–332 (1953)Google Scholar
  60. Reiter, M.: Wirkung von Frequenz, Natriumentzug und Strophanthin auf Kontraktionskraft und Alkaligehalt des Herzmuskels. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 227, 300–315 (1956)Google Scholar
  61. Repke, K.: Biochemie und Klinik der Digitalis. Internist 7, 418–425 (1966)Google Scholar
  62. Repke, K., Est, M., Portius, H. J.: Über die Ursache der Speciesunterschiede in der Digitalisempfindlichkeit. Biochem. Pharmacol. 14, 1785–1802 (1965)Google Scholar
  63. Russell, J. Q., Klaassen, O. D.: Species variation in the biliary excretion of ouabain. J. Pharmacol. exp. Ther. 183, 513–519 (1972)Google Scholar
  64. Sanyal, P. N., Saunders, P. R.: Effect of therapeutic and toxic concentrations of ouabain upon potassium contnet of myocardium. Proc. Soc. exp. Biol. (N. Y.) 106, 639–641 (1961)Google Scholar
  65. Schneider, M.: Die Pharmakokinetik von Digitoxin und Ouabain am isolierten, schlagenden Herzen des Meerschweinchens und der Ratte. Inauguraldissertation, Saarbrücken 1971Google Scholar
  66. Sevastikoglou, J. A., Ray, R. D., Hjertquist, S.-O., Bergquist, E.: Vitamin D and skeletal metabolism: Experimental studies in the rat. Acta orthop. scand., Suppl. 136, 31–40 (1970)Google Scholar
  67. Shirachi, D. Y., Allard, A. A., Trevor, A. J.: Partial purification and ouabain sensitivity of lubrol-extracted sodium-potassium transport ATPase from brain and cardiac tissues. Biochem. Pharmacol. 19, 2893–2906 (1970)Google Scholar
  68. Sjoerdsma, A., Fischer, C. S.: The fixation of radioactive digitoxin by isolated hearts. Circulation 4, 100–104 (1951)Google Scholar
  69. Skaletzki, B., Wollmann, H.: Die Sorbtion von Arzneistoffen an Plastmaterial. Pharmazie 28, 1–6 (1973)Google Scholar
  70. Straub, W.: Über die Resistenz der Ratten gegen k-Strophanthin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 84, 223–233 (1919)Google Scholar
  71. Straub, W.: Die Digitalisgruppe. In: Heffter's Handbuch exp. Pharmakol. II, 1355–1452 (1924)Google Scholar
  72. Sugimoto, J., Nagata, M., Kawaguchi, K.: Influence of trimetazidine on the inotropic action of strophanthin-G on guinea pig atria in abnormal ion environments. Jap. Circulat. J. 36, 953–961 (1972)Google Scholar
  73. Thomas, R. E., Roth-Schechter, B. F., Okita, G. T.: Synthesis and positive inotropic effect of strophanthidol 3-bromoacetate-19-H3. J. med. Chem. 13, 357–359 (1970)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • Uwe Fricke
    • 1
  • Ursula Hollborn
    • 1
  • Wolfgang Klaus
    • 1
  1. 1.Institut für Pharmakologie der Medizinische HochschuleHannoverGermany

Personalised recommendations